dental supporting tissues. 2, 6 CP has a multifactor etiology involving genetic and environmental (medications, stress, smoking, and diabetes mellitus [DM]) factors. 7, 8 DM is a chronic metabolic disorder with a multifactor etiology characterized by chronic hyperglycemia and the impaired metabolism of carbohydrates, fats, and proteins, resulting in defects in regard to the secretion and/or action of insulin. 9 Depending on its etiology, DM is classified as either type 1 or type 2 (DM2).
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Individuals with diabetes are approximately three times more susceptible to periodontitis, especially those with poor blood sugar control, which makes CP the sixth most common complication of DM; moreover, a bidirectional relationship is found between the two conditions. [11] [12] [13] [14] Periodontitis-causing bacterial infection generally does not differ between diabetic and nondiabetic individuals. However, the immune response to periodontal infection is quite differentiated in DM2, as individuals with this condition do not develop antibodies for the pathogens associated with periodontitis. 15 In this complex system of the homeostatic balance of two chronic conditions, the active form of the hormone 1,25-dihydroxyvitamin D (1, 25 [OH] 2 D), or simply, vitamin D, has considerable importance to bone metabolism, mineral homeostasis, and the modulation of the innate and/or adaptive immune response. [16] [17] [18] Vitamin D has been linked to a reduction in the risk of periodontal disease, as it stimulates the production of antimicrobial peptides (α-/β-defensins and cathelicidins) that have effects on a broad spectrum of microorganisms, 19, 20 thereby serving as an immunological modulator and activator of anti-inflammatory mechanisms. 17, 19 The action of vitamin D occurs through the activation of the vitamin D receptor (VDR), which is a transcription factor belonging to the nuclear receptor superfamily of steroid hormones, 16 coded by the VDR gene (12q12-q14) and expressed in nearly all human cells. 21, 22 VDR participates in the regulation of approximately 3% of the human genome, 23 and has been related to periodontal disease. 24 Single-nucleotide polymorphisms (SNP) in the VDR gene, such as FokI (rs2228570), BsmI (rs154410), ApaI (rs11168271), and TaqI (rs731236), have been studied in the context of periodontitis. [25] [26] [27] [28] [29] Other variants (Cdx2 [rs11568820] and GATA-1 [rs451635]) have been studied in other contexts, [30] [31] [32] [33] [34] [35] but have been investigated little in CP. The FokI variant has been related to an increase in generalized aggressive periodontitis in the Korean population, 25 and CP in the Japanese population. 26 The TaqI variant has been associated with an increased risk of early-onset periodontitis in the Chinese population. 27 TaqI and BsmI have been associated with periodontal disease in the Brazilian population. 29 Furthermore, the haplotypes formed among the BsmI, ApaI, and TaqI variants have been associated with the risk of CP in the Turkish population. 28 Considering the influence of functional SNP in the expression of VDR, the role of this nuclear receptor in immune response and bone metabolism, and the bidirectional relationship between CP and DM2, the aim of the present study was to evaluate the distribution of functional SNP (Fokl, Cdx2, and GATA) in the VDR and their relationship with CP and DM2 in a population from northeastern Brazil.
| MATERIAL S AND ME THODS

| Ethical considerations
All methods used in the present study received approval from 
| Inclusion criteria
For the study, the volunteers needed to be at least 35 years of age and have a minimum of eight natural teeth (excluding those with an indication for extraction). Volunteers in the DM2 + CP group needed to have a clinical diagnosis of both conditions, and those in the CP group needed to have a clinical diagnosis of only CP.
Individuals with neither conditions were included in the control group.
| Exclusion criteria
Individuals who used antibiotics or anti-inflammatory agents in the previous 6 months, those with conditions that compromised the immune system, those who had undergone periodontal treatment in the previous 6 months, pregnant or nursing women, smokers, and individuals who used an orthodontic appliance were excluded from the study.
| Clinical aspects
CP was characterized by inflammation (bleeding on probing), increased probing depth, and clinical attachment loss, following the recommendations of the American Academy of Periodontology.
4,5
The diagnosis was based on clinical and radiographic variables. CP was classified as mild, moderate, or severe in terms of severity and localized or generalized in terms of extent. 
| Statistical analyses
Allele and genotype frequencies were calculated by direct counts.
Adherence to the Hardy-Weinberg equilibrium was determined using χ 2 -test. Fisher's exact test was used to determine possible associations, employing 2 × 2 contingency tables in the R program. 37 For all analyses, 95% confidence intervals (CI) were calculated, and 
| RE SULTS
The sample was composed of 280 individuals: 116 (41.5%) with con- Table 2 ).
The DM2 + CP and CP groups had a higher mean age and monthly household income compared to the healthy individuals. Regarding the clinical variables, the DM2 + CP and CP had a lower mean number of teeth, as well as greater probing depth, clinical attachment F I G U R E 1 Relation of the single-nucleotide polymorphisms studied in the Defensin Beta 1, vitamin D receptor, and Dendritic CellSpecific Intercellular adhesion molecule-3-Grabbing Non-integrin genes
loss, gingival bleeding index, and visible plaque index than the healthy controls.
Significant differences among groups were also found with regard to allelic and genotypic distribution for SNP rs4516035 (GATA) of the VDR gene (Table 3 ). The C allele was significantly more frequent among the healthy individuals (34.8%) than those with DM2 + CP (23.5%) (odds ratio [OR] = .58, 95% CI: .35-.94, P = .022). Likewise, the CC allele was significantly more frequent among the healthy individuals (11.6%) than those with DM2 + CP (2.6%) (OR = .17, 95% CI: .03-.79, P = .015), suggesting that the presence of these variants might lead to a lower susceptibility to DM2 and CP. No other significant differences among groups were found for the other SNP investigated (Table 3) .
TA B L E 1 Epidemiological profile of the study participants (Table 4) . However, no significant differences were found among the groups.
Significant differences were found for genotype distribution according to the means of the clinical variables for SNP rs2228570 (FokI) in the DM2 + CP and control groups (Table 5 ). In the DM2 + CP group, mean probing depth in individuals with the AA genotype (1.99) was significantly lower than in individuals with the GG genotype (2.57) (P = .032). In the healthy controls, the mean visible plaque index was significantly lower in individuals with the GA genotype (12.86) than those with the GG genotype (19.51) (P = .036). No significant differences were found in the CP group or for the other SNP investigated.
In terms of the classification of periodontitis (severity and extent) in the DM2 + CP and CP groups, significant differences were found in the genotype distribution of the SNP in the VDR gene. For SNP rs2228570 (FokI), significant differences among genotypes were found regarding the extent of periodontitis in the DM2 + CP group (P = .018) and the severity of periodontitis in the CP group (P = .022) ( Table 6 ). For SNP rs4516035 (GATA), significant differences among genotypes were found regarding the extent of periodontitis in the CP group (P = .005) ( Table 7) .
| D ISCUSS I ON
CP is the sixth most frequent complication of DM2 and an infectious inflammatory disease initiated and maintained by an altered immune response to periodontopathogens, which inflame the periodontium and destroy both connective tissue and bone. 2 Vitamin D and polymorphisms in its receptor (VDR) have been related to the modulation of the risk of periodontal disease. 
TA B L E 2 Clinical-epidemiological profile of the study participants (quantitative variables)
In the present study, the distribution of functional SNP TA Although previous studies have reported an association between the FokI (rs2228570) variant and the risk of CP development in other populations, 25, 26 no significant differences were found among the groups in the population studied herein, which is in agreement with other findings in the literature. 24, [40] [41] [42] Moreover, the Cdx2 (rs11568820) variant was also not significantly associated with DM2
and CP in this population, which is in agreement with the findings in previous studies on periodontal disease. 32, 43, 44, 45 Despite the lack of differences in genotypic distribution among the groups, intragroup differences were found. In the DM2 + CP 
| CON CLUS ION
For the SNP rs4516035 (GATA) polymorphism of the VDR, the C allele and CC genotype were more frequent among healthy individuals, TA B L E 7 Genotype distribution of single-nucleotide polymorphism rs4516035 (GATA-1) of the vitamin D receptor gene according to severity and extent of chronic periodontitis (CP) in the diabetes mellitus type 2 (DM2) + CP and CP groups suggesting that the presence of these variants could lead to lower susceptibility to CP in individuals with DM2.
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